Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Jnj-56136379
2. Jnj-6379
1. Unii-2456kw2166
2. Bersacapavir [inn]
3. Bersacapavir [usan]
4. Jnj-6379
5. Jnj-56136379
6. 1638266-40-6
7. 2456kw2166
8. 1h-pyrrole-2-carboxamide, N-(3-cyano-4-fluorophenyl)-1-methyl-4-((((1s)-2,2,2-trifluoro-1-methylethyl)amino)sulfonyl)-
9. N-(3-cyano-4-fluorophenyl)-1-methyl-4-(((2s)-1,1,1-trifluoro-2-propanyl)sulfamoyl)-1hpyrrole-2-carboxamide
10. N-(3-cyano-4-fluorophenyl)-1-methyl-4-[[(2s)-1,1,1-trifluoropropan-2-yl]sulfamoyl]pyrrole-2-carboxamide
11. Bersacapavir [who-dd]
12. Chembl4744254
13. Schembl17700943
14. Ex-a5896
15. Who 11272
16. Hy-109168
17. Cs-0116353
| Molecular Weight | 418.4 g/mol |
|---|---|
| Molecular Formula | C16H14F4N4O3S |
| XLogP3 | 2.2 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 5 |
| Exact Mass | 418.07227414 g/mol |
| Monoisotopic Mass | 418.07227414 g/mol |
| Topological Polar Surface Area | 112 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 730 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antiviral Agents
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)
ABOUT THIS PAGE
67
PharmaCompass offers a list of JNJ-6379 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right JNJ-6379 manufacturer or JNJ-6379 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred JNJ-6379 manufacturer or JNJ-6379 supplier.
PharmaCompass also assists you with knowing the JNJ-6379 API Price utilized in the formulation of products. JNJ-6379 API Price is not always fixed or binding as the JNJ-6379 Price is obtained through a variety of data sources. The JNJ-6379 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A JNJ-6379 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of JNJ-6379, including repackagers and relabelers. The FDA regulates JNJ-6379 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. JNJ-6379 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A JNJ-6379 supplier is an individual or a company that provides JNJ-6379 active pharmaceutical ingredient (API) or JNJ-6379 finished formulations upon request. The JNJ-6379 suppliers may include JNJ-6379 API manufacturers, exporters, distributors and traders.
JNJ-6379 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of JNJ-6379 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right JNJ-6379 GMP manufacturer or JNJ-6379 GMP API supplier for your needs.
A JNJ-6379 CoA (Certificate of Analysis) is a formal document that attests to JNJ-6379's compliance with JNJ-6379 specifications and serves as a tool for batch-level quality control.
JNJ-6379 CoA mostly includes findings from lab analyses of a specific batch. For each JNJ-6379 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
JNJ-6379 may be tested according to a variety of international standards, such as European Pharmacopoeia (JNJ-6379 EP), JNJ-6379 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (JNJ-6379 USP).
